4 countries already involved in the Metastatic Breast Cancer GPS programme (scientific name: AURORA)

Intro text: 


Since its launch in 2014 the Metastatic Breast Cancer GPS (AURORA) has been activated in 9 hospitals in 4 different countries: Belgium, Luxembourg, Spain and Iceland. Additional sites in Germany, UK and Finland are expected to join in the coming months.

AURORA is an innovative, international programme set up to significantly improve our understanding of metastatic breast cancer, so that one day better treatments and potentially cures can be offered to patients with this disease.
The programme aims to understand why breast cancer spreads (metastasises) and why some metastases respond poorly to standard treatment while others respond very well. 

In total 1300 women and men from up to 80 hospitals in 14 European countries are expected to take part in the programme.

Activated sites on 27 May 2015:

  • Institut Jules Bordet (Brussels), Belgium
  • Centre Hospitalier Luxembourg (Luxembourg), Luxembourg
  • Landspitali University Hospital of Iceland (Gardabaer), Iceland
  • Hospital del Mar (Barcelona), Spain
  • HU Arnau de Vilanova (Lleida), Spain
  • Hospital Universitario 12 Octubre (Madrid), Spain
  • Hospital Vall d'Hebron (Barcelona), Spain
  • MD Anderson Cancer Center (Madrid), Spain
  • CIOCC (Centro Integral Oncologico "Clara Campal") (Madrid), Spain

Read more about the AURORA project